Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Market Capitalization (2010 - 2026)

Palatin Technologies' (PTN) quarterly Market Capitalization came in at $68.1 million in Q1 2026, up 345.99% on a YoY basis from $15.3 million in Q1 2025, and up 74.47% quarter-over-quarter from $39.1 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Market Capitalization (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Market Capitalization for 17 consecutive years, with $68.1 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Market Capitalization rose 345.99% year-over-year to $68.1 million; the trailing twelve-month figure through Mar 2026 stood at $68.1 million (up 345.99% YoY), and the FY2025 full-year result was $102.9 million, down 92.82% from the prior year.
  • Market Capitalization climbed to $68.1 million in Q1 2026 per PTN's latest filing, from $39.1 million in the prior quarter.
  • Across five years, Market Capitalization topped out at $133.3 billion in Q1 2022 and bottomed at $3.7 million in Q2 2025.
  • Historically, Market Capitalization has averaged $20.9 billion across 5 years, with a median of $1.3 billion in 2024.
  • The sharpest annual moves came in 2025 and 2026: Market Capitalization plunged 99.74% in 2025, then surged 345.99% in 2026.
  • Over 5 years, Market Capitalization stood at $29.7 billion in 2022, then tumbled by 90.4% to $2.8 billion in 2023, then tumbled by 54.27% to $1.3 billion in 2024, then slumped by 97.0% to $39.1 million in 2025, then soared by 74.47% to $68.1 million in 2026.
  • According to Business Quant data, Market Capitalization over the past three periods registered $68.1 million, $39.1 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 68.15 Mn
Dec 31, 2025 39.06 Mn
Sep 30, 2025 7.71 Mn
Jun 30, 2025 3.69 Mn
Mar 31, 2025 15.28 Mn
Dec 31, 2024 1.30 Bn
Sep 30, 2024 869.89 Mn
Jun 30, 2024 1.43 Bn
Mar 31, 2024 1.34 Bn
Dec 31, 2023 2.85 Bn
Sep 30, 2023 901.97 Mn
Jun 30, 2023 1.22 Bn
Mar 31, 2023 31.87 Bn
Dec 31, 2022 29.67 Bn
Sep 30, 2022 68.61 Bn
Jun 30, 2022 81.12 Bn
Mar 31, 2022 133.27 Bn
Dec 31, 2021 147.71 Bn
Sep 30, 2021 127.22 Bn
Jun 30, 2021 175.41 Bn